Clinical Trials Logo

Clinical Trial Summary

Alzheimer's disease (AD) is a progressive and multifactorial neurodegenerative disease. Before progressing to AD, individuals may experience mild cognitive impairment (MCI). While these individuals with MCI have an increased risk of progressing to AD, emerging studies reveal that obstructive sleep apnea (OSA) is a risk factor for both MCI an well as AD. Thus, it is worthwhile to identify clinical management or interventions that retard the conversion of subjects with comorbid MCI and OSA and AD. A randomized, double-blind, placebo-controlled study proposed herein aims to examine the effect of trazodone on reducing level sST2 and protein markers that are associated with neurodegeneration in the plasma of subjects with comorbid OSA and MCI. In this 1-year study, 124 study participants will undergo a series of neurocognitive assessments.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05209035
Study type Interventional
Source Chinese University of Hong Kong
Contact Timothy Kwok
Phone +852 3505 3173
Email [email protected]
Status Not yet recruiting
Phase Phase 4
Start date May 1, 2022
Completion date December 31, 2026

See also
  Status Clinical Trial Phase
Recruiting NCT04547543 - Follow-up of Apneic Patients by Visio-consultation N/A
Completed NCT02515357 - Mediterranean Diet/Lifestyle Intervention in Obstructive Sleep Apnea N/A
Recruiting NCT03189173 - Combined Upper-airway and Breathing Control Therapies for Obstructive Sleep Apnea Phase 2
Completed NCT04084899 - The Effect of CPAP on Lung Hyperinflation in Patients With OSA
Active, not recruiting NCT03032029 - Registry on the Treatment of Central and Complex Sleep-Disordered Breathing With Adaptive Servo-Ventilation
Recruiting NCT04028011 - Clinical Evaluation of a Wearable Technology for the Diagnosis of Sleep Apnoea
Recruiting NCT05253963 - Acute Effect of CPAP on Weight in Patients With Obstructive Sleep Apnea N/A
Completed NCT03589417 - Postural Stability, Balance and Fall Risk in Patients With Obstructive Sleep Apnea
Recruiting NCT03868618 - Dual-sided Hypoglossal neRvE stimulAtion for the treatMent of Obstructive Sleep Apnea N/A
Recruiting NCT04115878 - Medications for Obstructive Sleep Apnea In Children With Down Syndrome Phase 2
Recruiting NCT04335994 - ENhancing Outcomes in Cognitive Impairment Through Use of Home Sleep ApNea Testing N/A
Withdrawn NCT04063436 - Evaluation of a New Nasal Pillows Mask for the Treatment of Obstructive Sleep Apnea N/A
Recruiting NCT04572269 - Metabolomics of Obstructive Sleep Apnea
Withdrawn NCT04011358 - Retinal Vein Occlusion and Obstructive Sleep Apnea: A Case Control Study N/A
Completed NCT02878590 - Clinical Study for the BONGO Device in the Treatment of Obstructive Sleep Apnea (OSA) N/A
Completed NCT03060915 - Actigraphy Sleep Parameters in Obstructive Sleep Apnea Patient's N/A
Completed NCT03246477 - Long-term Impact of Maxillomandibular Advancement Osteotomy on Sleep Apnea Patients
Completed NCT02894242 - The Evaluation of a Nasal Pillows Mask for the Treatment of Obstructive Sleep Apnea (OSA) N/A
Recruiting NCT02431507 - Magnetic Apnea Prevention(MAGNAP) Device to Treat Obstructive Sleep Apnea:First-In-Human Study of Feasibility and Safety N/A
Recruiting NCT02385864 - CPAP Effect on Blood Pressure and Arterial Stiffness in Obstructive Sleep Apnea Patients With Resistant Hypertension N/A